Background illustration for clinical trials search

Paid Clinical Trials Orlando

Discover 1,033 paid clinical trials in Orlando, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Post-Market Domestic (US) and International Data Collection to Assess the Truliant Knee System

for
Knee Arthroplasty, Total
Location: DeLand FL, Charleston SC, Akron OH, Aurora CO,
Sponsor: Exactech

Sex: All

Age: 18+

Code: NCT05653102

Recruiting

Pivotal Study of the Velocity™ pAVF System

for
Chronic Kidney Disease, Hemodialysis Access,
Location: Cocoa FL, Jacksonville FL, Dothan AL, Orangeburg SC,
Sponsor: Venova Medical

Sex: All

Age: 18 - 70+

Code: NCT07153939

Recruiting

FastWire REvascularisation of Extremities, (For LOWer Limbs) - FREEFLOW

for
Chronic Total Occlusion of Artery of the Extremities
Location: Cocoa FL, Chattanooga TN, Gray LA, Wilmington DE,
Sponsor: Versono Medical Ltd

Sex: All

Age: 18 - 70+

Code: NCT06492733

Recruiting

A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

for
Multiple Myeloma, Newly Diagnosed Multiple Myeloma
Location: Lady Lake FL, Saint Augustine FL, Englewood FL,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06679101

Phase 3, Recruiting

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

for
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8,
Location: Winter Haven FL, Plant City FL, Tampa FL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06498635

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Winter Haven FL, Lakeland FL, Plant City FL, Tampa FL,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT06876714

Phase 3, Recruiting

The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

for
Atrial Fibrillation
Location: Winter Haven FL, Clearwater FL, Gainesville FL,
Sponsor: Johns Hopkins University

Sex: All

Age: 22 - 70+

Code: NCT05836987

Phase 3, Recruiting

Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias

for
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation,
Location: Winterhaven FL, Tampa FL, Sarasota FL, Jacksonville FL,
Sponsor: Heart Rhythm Clinical and Research Solutions, LLC

Sex: All

Age: 18+

Code: NCT04088071

Recruiting

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

for
Breast Cancer
Location: Winter Haven FL, Rockledge FL, Lakeland FL,
Sponsor: Agendia

Sex: All

Age: 18+

Code: NCT03053193

Recruiting

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

for
Breast Carcinoma, Colorectal Carcinoma,
Location: Winter Haven FL, Plant City FL, Tampa FL,
Sponsor: Wake Forest University Health Sciences

Sex: All

Age: 18+

Code: NCT06418204

Recruiting

Validation of the English Version of the FIMA Questionnaire

for
Elderly Persons
Location: Winter Haven FL
Sponsor: Wroclaw Medical University

Sex: All

Age: 65+

Code: NCT04168424

Recruiting

A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis

for
Rheumatoid Arthritis
Location: Winter Haven FL, Myrtle Beach SC, Marietta GA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07276581

Phase 2, Recruiting

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

for
Acute Coronary Syndrome
Location: Winter Haven FL, Ocala FL, Tampa FL, Safety Harbor FL,
Sponsor: DalCor Pharmaceuticals

Sex: All

Age: 45+

Code: NCT05918861

Phase 3, Recruiting

HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

for
Type 2 Diabetes
Location: Edgewater FL, Fort Myers FL, Miramar FL, Doral FL,
Sponsor: Housey Healthcare ULC

Sex: All

Age: 18+

Code: NCT07546929

Phase 2, Recruiting

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Winter Haven FL, Tampa FL, Safety Harbor FL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06058377

Phase 3, Recruiting
New

Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)

for
Non-Small Cell Lung Cancer
Location: Palm Bay FL, Winchester VA, Beaumont TX, San Antonio TX,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07680790

Phase 3, Recruiting

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

for
NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer,
Location: Rockledge FL, St. Petersburg FL, Stuart FL,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06881784

Phase 3, Recruiting

A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

for
Non-Small Cell Lung Cancer, c-MET
Location: Rockledge FL, Tampa FL, Jacksonville FL, Knoxville TN,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07155187

Phase 2, Phase 3, Recruiting

A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures

for
Stereotypical Prolonged Seizures
Location: Rockledge FL, Tampa FL, Jacksonville FL, Miami FL,
Sponsor: UCB Biopharma SRL

Sex: All

Age: 12+

Code: NCT05077904

Phase 3, Recruiting

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

for
Generalized Myasthenia Gravis
Location: Rockledge FL, Ormond Beach FL, Tampa FL, Clearwater FL,
Sponsor: Immunovant Sciences GmbH

Sex: All

Age: 18 - 70+

Code: NCT07039916

Phase 3, Recruiting

Orlando, Florida has a well-developed healthcare system with several prominent medical research facilities, making it an important hub for a diverse array of clinical trials. Notable institutions such as the Orlando Health Cancer Institute and the University of Central Florida's College of Medicine are at the forefront of these research initiatives.

Each medical center in Orlando focuses on innovative studies across various fields, including oncology, cardiovascular health, and neurological disorders, positioning Orlando as a vital contributor in advancing medical research and treatment options.

Why choose Orlando for clinical trials?

Orlando offers a vast array of advantages for individuals considering participation in clinical trials. The city is home to a diverse population, which helps create a wide range of participants, enhancing the reliability and applicability of research findings.

Additionally, Orlando’s thriving healthcare ecosystem fosters an environment of innovation and collaboration, with a strong emphasis on advancing medical research and treatment. By participating in a clinical trial in Orlando, participants not only gain access to innovative therapies but also play a crucial role in advancing scientific knowledge.

Common conditions studied in Orlando

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Orlando